Virus-free CRISPR knock-in of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells.
Shankar K, Zingler-Hoslet I, Tabima DM, Zima S, Shi L, Gimse K, Forsberg MH, Katta V, Davis SZ, Maldonado D, Russell BE, Murtaza M, Tsai SQ, Ayuso JM, Capitini CM, Saha K.
Shankar K, et al. Among authors: shi l.
Mol Ther. 2025 Jan 14:S1525-0016(25)00028-0. doi: 10.1016/j.ymthe.2025.01.024. Online ahead of print.
Mol Ther. 2025.
PMID: 39815622